Isolevuglandin-protein adducts in humans: Products of free radical- induced lipid oxidation through the isoprostane pathway

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1485, Issue 2-3, 2000, Pages 225-235

  Salomon, Robert G ^a   Batyreva, Eugenia ^a   Kaur, Kamaljit ^a   Sprecher, Dennis L ^b   Schreiber, Martin J ^b   Crabb, John W ^b   Penn, Marc S ^b   Dicorleto, Angela M ^b   Hazen, Stanley L ^b   Podrez, Eugene A ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Isolevuglandin; Isoprostane; Levuglandin; Renal disease

Indexed keywords

APOLIPOPROTEIN B; AUTOANTIBODY; CHOLESTEROL; ENDOPEROXIDE; FREE RADICAL; ISOLEVUGLANDIN; ISOPROSTANE; LEVUGLANDIN E2; LIPID; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LIPID OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REACTION ANALYSIS;

ADULT; ANIMALS; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; AUTOANTIBODIES; CHOLESTEROL; FREE RADICALS; HEMOCYANIN; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; MIDDLE AGED; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PROSTAGLANDIN H2; PROSTAGLANDINS E; PROSTAGLANDINS H; RABBITS; STEREOISOMERISM;

EID: 0034738004     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00038-X     Document Type: Article

References (38)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. N. Engl. J. Med. 320:1989;915-924.
2. Clausen J. Acta Neurol. Scand. 70:1984;345-355.
3. Davies K.J.A. Biochem. Soc. Symp. 61:1995;1-31.
4. Lindner A., Charra B., Sherrard D.J., Scribner B.H. N. Engl. J. Med. 290:1974;697-701.
5. Salomon R.G., Miller D.B., Zagorski M.G., Coughlin D.J. J. Am. Chem. Soc. 106:1984;6049-6060.
6. Morrow J.D., Harris T.M., Roberts L.J. I. Anal. Biochem. 184:1990;1-10.
7. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. I. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387.
8. Salomon R.G., Subbanagounder G., Singh U., O'Neil J., Hoff H.F. Chem. Res. Toxicol. 10:1997;750-759.
9. Brame C.J., Salomon R.G., Morrow J.D., Roberts L.J. II. J. Biol. Chem. 274:1999;13139-13146.
10. Salomon R.G., Subbanagounder G., O'Neil J., Kaur K., Smith M.A., Hoff H.F., Perry G., Monnier V.M. Chem. Res. Toxicol. 10:1997;536-545.
11. Salomon R.G., Sha W., Brame C., Kaur K., Subbanagounder G., O'Neil J., Hoff H.F., Roberts L.J. II. J. Biol. Chem. 274:1999;20271-20280.
12. E. Harlow and L. Lane, in: Antibodies a Laboratory Manual, Cold Spring Harbor Laboratory, NY, 1988, pp. 312-318.
13. Bradford M.M. Anal. Biochem. 72:1976;248-254.
14. Laemmli U.K. Nature. 227:1970;680-685.
15. Allain C.A., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Clin. Chem. 20:1974;470-477.
16. Podrez E.A., O'Neil J., Salomon R.G., Schreiber M.J., Hoff H.F. Kidney Int. 54:1998;637-645.
17. Choi S.Y., Pang L., Kern P.A., Kayden H.J., Curtiss L.K., Vanni-Reyes T.M., Goldberg I.J. J. Lipid Res. 38:1997;77-85.
18. Maggi E., Bellassi R., Gazo A., Seccia M., Bellomo G. Kidney Int. 46:1994;869-876.
19. Salonen J.T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nuussönen K., Palinski W., Witztum J.L. Lancet. 339:1992;883-887.
20. Maggi E., Chiesa R., Melissano G., Castellano R., Astore D., Grossi A., Finardi G., Bellomo G. Arterioscler. Thromb. 14:1994;1892-1899.
21. Witztum J.L., Steinberg D. J. Clin. Invest. 88:1991;1785-1792.
22. Witztum J.L. Am. J. Med. 94:1993;347-356.
23. Reaven P.D., Witztum J.L. Endocrinologist. 5:1995;44-54.
24. Bellazzi R., Maggi E., Bellomo G., Finardi G., Gazo A., Nai M., Romanini D., Falashi F., Frattoni A., Perani G. Adv. Perit. Dial. 9:1993;312-317.
25. Salmon S., Maziere C., Theron L., Beucler I., Jarrier-Ayrault M., Goldstein S., Polonovski J. Biochim. Biophys. Acta. 920:1987;215-220.
26. Kotani K., Maekawa M., Kanno T., Kondo A., Toda N., Manabe M. Biochim. Biophys. Acta. 1215:1994;121-125.
27. Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D. J. Clin. Invest. 95:1995;2611-2619.
28. Itabe H., Yamamoto H., Imanaka T., Shimamura K., Uchiyama H., Kimura J., Sanaka T., Hata Y., Takano T. J. Lipid Res. 37:1996;45-53.
29. Salomon R.G., Jirousek M.R., Ghosh S., Sharma R.B. Prostaglandins. 34:1987;643-656.
30. Iyer R.S., Ghosh S., Salomon R.G. Prostaglandins. 37:1989;471-480.
31. Jirousek M.R., Murthi K.K., Salomon R.G. Prostaglandins. 40:1990;187-203.
32. O'Brien K.D., Alpers C.E., Hokanson J.E., Wang S., Chait A. Circulation. 94:1996;1216-1225.
33. Murthi K., Salomon R.G., Sternlicht H. Prostaglandins. 39:1990;611-622.
34. Murthi K.K., Friedman L.R., Oleinick N.L., Salomon R.G. Biochemistry. 32:1993;4090-4097.
35. Hoppe G., Subbanagounder G., O'Neil J., Salomon R.G., Hoff H.F. Biochim. Biophys. Acta. 1344:1997;1-5.
36. Schmidley J.W., Dadson J., Iyer R.S., Salomon R.G. Prostaglandins Leukot. Essent. Fatty Acids. 47:1992;105-109.
37. Morrow J.D., Roberts L.J. II. Biochem. Pharmacol. 51:1996;1-9.
38. Basu S. Prostaglandins Leukot. Essent. Fatty Acids. 58:1998;319-325.